Navigation Links
Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference
Date:12/7/2009

DOYLESTOWN, Pa., Dec. 7 /PRNewswire/ -- Patricia Scheller, CEO of Prescient Medical, Inc., will be among the speakers at the Galen Institute's "The Value of Innovation in Health Care" conference. The conference will take place on Wednesday, December 9th in Washington DC at the Columbus Club at Union Station.

The Galen Institute is a non-profit public policy research organization focusing on health and tax policy.

"I'm very pleased to be part of the Galen Institute's conference," said Ms. Scheller. "As the debate on health care reform continues, there appears to be bipartisan agreement that continued innovation in medical research and the development of pioneering medical technology is critical. The US has historically led the world in advancing medical progress and the policy initiatives being discussed have the potential to profoundly impact our future position. The Galen Institute's conference offers a wonderful opportunity to provide input to lawmakers on how their policies can promote innovation."

The event unites policy experts, elected officials, and leaders in a number of health care-related industries to discuss the effects of health care reform on innovation. Prescient Medical has developed two breakthrough interventional cardiology solutions: the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System.

The vProtect(TM) Luminal Shield is a novel self-expanding coronary stent-like Shield that received CE Mark certification in August, 2009, allowing it to be marketed in Europe for improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease. The Shield was recently honored with Frost & Sullivan's 2009 North American Product Innovation of the Year Award. Designed specifically to minimize arterial injury and its consequences, the Shield is ideal for treating softer plaques, such as those that are typically associated with heart attacks.

The vPredict(TM) Optical Catheter System is being developed for the detection and characterization of soft plaque. Its technology platform is based on Raman spectroscopy, a highly sensitive technique proven in numerous non-clinical applications. The vPredict(TM) System detects clinically important compounds, including cholesterols, in the vessel wall and plaque. The goal of the vPredict(TM) System is to provide physicians with information to identify patients at risk for a heart attack and treat them proactively.

For more information on Prescient Medical or its products, please contact Ilana Odess, General Manager of Prescient Medical, at: iodess@pmivp.com.

About Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the 2009 Frost and Sullivan Award for Product Innovation of the Year Award for vProtect(TM) Luminal Shield. For more information about Prescient Medical and its products, please visit www.prescientmedical.com.

SOURCE Prescient Medical, Inc.


'/>"/>
SOURCE Prescient Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prescient Medical vProtect(TM) Luminal Shield Receives North American Product Innovation of the Year Award from Frost & Sullivan
2. Prescient Medical Inc. Featured on FOX Business Network
3. vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark
4. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
5. Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness
6. Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California)
7. Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical, Inc.
8. Entest BioMedical, Inc. Discusses How Therapies in Development May Yield Lucrative Revenue Streams for the Company
9. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
10. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
11. China Sky One Medical, Inc. Exports Pain Relief Patch to Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology: